Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities

Alterations in non-driver genes represent an emerging class of potential therapeutic targets in cancer. Hundreds to thousands of non-driver genes undergo loss of heterozygosity (LOH) events per tumor, generating discrete differences between tumor and normal cells. Here we interrogate LOH of polymorp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nichols, Caitlin A., Gibson, William J., Brown, Meredith S., Kosmicki, Jack A., Busanovich, John P., Wei, Hope, Urbanski, Laura M., Curimjee, Naomi, Berger, Ashton C., Gao, Galen F., Cherniack, Andrew D., Dhe-Paganon, Sirano, Paolella, Brenton R., Beroukhim, Rameen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239950/
https://www.ncbi.nlm.nih.gov/pubmed/32433464
http://dx.doi.org/10.1038/s41467-020-16399-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239950/
https://www.ncbi.nlm.nih.gov/pubmed/32433464
http://dx.doi.org/10.1038/s41467-020-16399-y

Ejemplares similares